CollPlant Biotechnologies
CLGN
CLGN
13 hedge funds and large institutions have $7.59M invested in CollPlant Biotechnologies in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less call options, than puts
Call options by funds: $1K | Put options by funds: $3K
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
13
Holding in Top 10
–
Calls
$1K
Puts
$3K
Top Buyers
| 1 | +$334K | |
| 2 | +$239K | |
| 3 | +$34.8K | |
| 4 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$30.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$25.6K |
Top Sellers
| 1 | -$633K | |
| 2 | -$148K | |
| 3 | -$9K | |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$3.19K |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.37K |